Back
Corporate News
Biofil Chemicals to review quarterly financial results at August 11 board meeting
01-Aug-2026, 12:57
Biofil Chemicals and Pharmaceuticals Limited will hold a meeting of its Board of Directors on August 11, 2026, to consider and approve the un-audited financial results for the quarter ended June 30, 2026, along with the limited review report thereon, according to a regulatory filing. The company’s BSE scrip code is 524396 and NSE symbol is BIOFILCHEM, with ISIN INE829A01014. A trading window for designated persons, immediate relatives, and connected persons will open 48 hours after the declaration of the financial results.
Biofil Chemicals and Pharmaceuticals Limited will hold a meeting of its Board of Directors on August 11, 2026, to consider and approve the un-audited financial results for the quarter ended June 30, 2026, along with the limited review report thereon, according to a regulatory filing. The company’s BSE scrip code is 524396 and NSE symbol is BIOFILCHEM, with ISIN INE829A01014. A trading window for designated persons, immediate relatives, and connected persons will open 48 hours after the declaration of the financial results.